Relevant aspects of golden retriever muscular dystrophy for the study of Duchenne muscular dystrophy in humans

被引:1
作者
Engracia de Moraes, Julieta Rodini [1 ]
Mouri Malvestio, Lygia Maria [2 ]
Martins, Isabela Mancini [1 ]
Erdmann Mosko, Patricia Regina [3 ]
Engracia Filho, Jair Rodini [3 ]
de Moraes, Flavio Ruas [1 ]
机构
[1] Univ Estadual Paulista UNESP, FCAV, BR-14884900 Jaboticabal, SP, Brazil
[2] Escola Med Vet, Fac Merid IMED, Passo Fundo, RS, Brazil
[3] Pontificia Univ Catolica Parana PUC PR, PPGCA, Curitiba, PR, Brazil
来源
CIENCIA RURAL | 2017年 / 47卷 / 10期
基金
巴西圣保罗研究基金会;
关键词
Duchenne muscular dystrophy; animal model; dystrophic Golden Retriever; ANIMAL-MODELS; MUSCLE FUNCTION; CANINE MODEL; STEM-CELLS; GENE; CARDIOMYOPATHY; EXPRESSION; TRANSDUCTION; INJECTION; MUTATION;
D O I
10.1590/0103-8478cr20160470
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
Golden Retriever muscular dystrophy (GRMD) is the most representative model for studying Duchenne muscular dystrophy (DMD) in humans, owing its phenotypic expression. DMD is a recessive disorder linked to the X chromosome in which the loss of dystrophin induces progressive weakness and degeneration of the skeletal and cardiac muscles, which lead to replacement by connective and adipose tissues. Onset of clinical signs occurs between 2 and 5 years of age, and many patients die from heart or respiratory failure. The main studies concerning dystrophic Golden Retrievers (DGR) sought to elucidate the pathophysiology of the disease and its clinical implications to develop therapies and alternative treatments to improve the quality of life and increase longevity of DMD patients. This review presents an overview of relevant contributions of the DGR model for elucidating DMD in humans.
引用
收藏
页数:11
相关论文
共 56 条
[1]   Animal models for muscular dystrophy: valuable tools for the development of therapies [J].
Allamand, V ;
Campbell, KP .
HUMAN MOLECULAR GENETICS, 2000, 9 (16) :2459-2467
[2]  
[Anonymous], INT C NEUR DIS 1994
[3]   Bortezomib (PS-341) Treatment Decreases Inflammation and Partially Rescues the Expression of the Dystrophin-Glycoprotein Complex in GRMD Dogs [J].
Araujo, Karla P. C. ;
Bonuccelli, Gloria ;
Duarte, Caio N. ;
Gaiad, Thais P. ;
Moreira, Dayson F. ;
Feder, David ;
Belizario, Jose E. ;
Miglino, Maria A. ;
Lisanti, Michael P. ;
Ambrosio, Carlos E. .
PLOS ONE, 2013, 8 (04)
[4]   Dystrophin-deficient muscular dystrophy in a weimaraner [J].
Baltzer, Wendy Irene ;
Calise, David V. ;
Leving, Jonathan M. ;
Shelton, G. D. ;
Edwards, John F. ;
Steiner, Joerg M. .
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2007, 43 (04) :227-232
[5]   THE VALUE OF MAMMALIAN MODELS FOR DUCHENNE MUSCULAR DYSTROPHY IN DEVELOPING THERAPEUTIC STRATEGIES [J].
Banks, Glen B. ;
Chamberlain, Jeffrey S. .
MOUSE MODELS OF DEVELOPMENTAL GENETIC DISEASE, 2008, 84 :431-453
[6]   MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy [J].
Barbash, I. M. ;
Cecchini, S. ;
Faranesh, A. Z. ;
Virag, T. ;
Li, L. ;
Yang, Y. ;
Hoyt, R. F. ;
Kornegay, J. N. ;
Bogan, J. R. ;
Garcia, L. ;
Lederman, R. J. ;
Kotin, R. M. .
GENE THERAPY, 2013, 20 (03) :274-282
[7]   Effects of an Immunosuppressive Treatment in the GRMD Dog Model of Duchenne Muscular Dystrophy [J].
Barthelemy, Ines ;
Uriarte, Ane ;
Drougard, Carole ;
Unterfinger, Yves ;
Thibaud, Jean-Laurent ;
Blot, Stephane .
PLOS ONE, 2012, 7 (11)
[8]   In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide [J].
Bartlett, RJ ;
Stockinger, S ;
Denis, MM ;
Bartlett, WT ;
Inverardi, L ;
Le, TT ;
Man, NT ;
Morris, GE ;
Bogan, DJ ;
Metcalf-Bogan, J ;
Kornegay, JN .
NATURE BIOTECHNOLOGY, 2000, 18 (06) :615-622
[9]   Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy [J].
Bengtsson, Niclas E. ;
Hall, John K. ;
Odom, Guy L. ;
Phelps, Michael P. ;
Andrus, Colin R. ;
Hawkins, R. David ;
Hauschka, Stephen D. ;
Chamberlain, Joel R. ;
Chamberlain, Jeffrey S. .
NATURE COMMUNICATIONS, 2017, 8
[10]  
Beretta D. C., 2014, Brazilian Journal of Veterinary Pathology, V7, P70